Ashley Delaunois
Psychiatric/Mental Health · Terre Haute, INNPI 1699397539
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.6% of the total across 155 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 18.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,240 and has fallen 76.5% since, to $292 in 2025.
Across 155 payments — averaging $24.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$712
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$624
- Johnson & Johnson$304
- AbbVie$294
- Otsuka America Pharmaceutical, Inc.$237
- Lundbeck LLC$211
- plus $1K from 21 others
What the payments were for
- Food & beverage$3,80199%
- Education$561%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 15 | $712 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 28 | $624 |
| Johnson & Johnson | 17 | $304 |
| AbbVie | 16 | $294 |
| Otsuka America Pharmaceutical, Inc. | 11 | $237 |
| Lundbeck LLC | 12 | $211 |
| Amgen | 10 | $209 |
| Vertos Medical, Inc. | 1 | $201 |
| E.r. Squibb & Sons, L.L.C. | 4 | $181 |
| Axsome Therapeutics, Inc. | 2 | $141 |
| Teva Pharmaceuticals USA, Inc. | 9 | $135 |
| Sunovion Pharmaceuticals Inc. | 7 | $130 |
| Sage Therapeutics, LLC | 1 | $87 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $72 |
| Vanda Pharmaceuticals Inc. | 2 | $48 |
| Novo Nordisk | 3 | $41 |
| Neurocrine Biosciences, Inc. | 2 | $35 |
| Corium, LLC | 2 | $31 |
| Ironshore Pharmaceuticals Inc. | 2 | $29 |
| Indivior Inc. | 1 | $20 |
| Novartis | 1 | $19 |
| Si-bone, Inc. | 1 | $19 |
| Radius Health, Inc. | 1 | $18 |
| Idorsia Pharmaceuticals US Inc | 1 | $17 |
| Lilly USA, LLC | 1 | $16 |
| Supernus Pharmaceuticals, Inc. | 1 | $13 |
| Medtronic | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,857 in reported general payments places this provider in the 85th percentile of 729 psychiatric/mental health providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| DayvigoLemborexant | 11 | $3,649 |
| Duloxetine Hcl | 21 | $649 |
| Clonazepam | 25 | $212 |
| Mirtazapine | 12 | $60 |
| Lorazepam | 17 | $30 |
| Trazodone Hcl | 11 | $17 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Terre Haute
- Brooke KempfTerre Haute$1.1M
- Jennifer ScottTerre Haute$10K
- Lisa ReinhardtTerre Haute$7K
- Margaret BrumfieldTerre Haute$5K
- Gerald LewisMerrillville$336K
- Lauren LutzColumbus$320K
- Sonya RuedlingerIndianapolis$134K
- Trina GreenwaldMarion$107K
- Paul DuncanJeffersonville$46K
- Morgan StamperConnersville$42K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.